Supplement
Issue:
New Approaches to Measuring Value in Oncology Therapy
Volume:
18
Number:
11 Suppl
ARTICLES
Yang Lu, PhD; John R. Penrod, PhD; Neeraj Sood, PhD; Saarah Woodby, BA; and Tomas Philipson, PhD
Wesley Yin, PhD; John R. Penrod, PhD; J. Ross Maclean, MD; Darius N. Lakdawalla, PhD; and Tomas Philipson, PhD
Although clinical trial data have quantified patient survival gains associated with tyrosine kinase inhibitors in chronic myeloid leukemia, the overall value of these benefits is unknown.
Yuri Sanchez, PhD; John R. Penrod, PhD; Xiaoli Lily Qiu, PhD; John Romley, PhD; Julia Thornton Snider, PhD; and Tomas Philipson, PhD
Theodore Darkow, PharmD; J. Ross Maclean, MD; Geoffrey F. Joyce, PhD; Dana Goldman, PhD; and Darius N. Lakdawalla, PhD
AUTHOR INDEX